UEG's content platform for gastroenterology education bringing recordings, courses, guidelines, and more together in one place.

UEG Week Berlin 2025 Recordings Gut Guide online What's new on Gutflix

Trending on Gutflix

Rate for better recommendations!

Your feedback helps us show you more of what you like and less of what you dislike!

More of this!

We will show you more similar content.

Not for me!

We won't suggest this again.

Bookmark!

Save this content for later!

New to myUEG? Create an account! Log In with myUEG account

UEG Poster

Audio / Video Poster

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

UPDATED OVERVIEW OF CLINICAL CHARACTERISTICS AND UNDERLYING CAUSES OF DYSPHAGIA IN THE OUTPATIENT SETTING: REAL-LIFE EXPERIENCE FROM A TERTIARY CENTRE

Francesco Calabrese 1, ANDREA PASTA 1, Luca Barbera 1, Elisa Marabotto 1, Giorgia Bodini 1, Edoardo Giovanni Giannini 1, Manuele Furnari 1

Affiliations

1 University of Genoa, Genova, Italy

Summary

AI Generated

In a retrospective cohort of 78 outpatients with incident dysphagia, eosinophilic esophagitis was the most common diagnosis (15.4%), followed by achalasia (9.0%), with systematic esophageal biopsies detecting EoE in 41.7% of cases without endoscopic features.

Among 78 patients presenting with dysphagia to an outpatient gastroenterology clinic (June–December 2022), eosinophilic esophagitis (EoE) was identified in 12 patients (15.4%) and achalasia in 7 patients (9.0%).
Esophageal biopsies were performed in 52 of 78 patients (66.6%), with 28 showing histologic abnormalities; notably, 5 of 12 EoE cases (41.7%) had no mucosal endoscopic evidence of the disease.
High-resolution manometry, performed in 22 patients after negative endoscopy and/or histology, showed abnormal findings in 77.3% of tests, with achalasia being the most common manometric diagnosis.
The authors propose that biopsies should always be performed in patients with dysphagia regardless of endoscopic findings, reporting that systematic biopsy increased diagnostic yield by 20%.
The material is most relevant to gastroenterologists evaluating dysphagia in outpatient settings and considering diagnostic algorithms for this symptom.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Introduction

Dysphagia is a common and alarming symptom, which harbours the risk of organic diseases. Its incidence is increasing in the last decades worldwide, both in the young and elderly population. However, epidemiological and clinical data related to dysphagia patients are lacking. Thus, we aimed to provide an updated analysis of the main underlying causes of dysphagia in outpatient clinic.

Aims & Methods

We retrospectively evaluated consecutive patients referred from June 2022 to December 2022 to our outpatient clinic, suffering from incident dysphagia as the main symptom at the index visit. Patients already previously evaluated were excluded. After clinical evaluation, all the subjects underwent esophago-gastro-duodenal endoscopy (EGDS) as the first diagnostic exam, during which, up to clinical suspect and endoscopist evaluation, biopsies of the oesophagus and/or cardias were made. According to clinician assessment, execution of high-resolution manometry (HRM) was also performed.

Results

During the study period 700 first outpatient visits were performed. A total of 78 patients met the inclusion criteria and were then involved in the study. Esophageal dysphagia was the most frequently reported symptom (65/78, 83.3%), followed by oropharyngeal dysphagia (8/78, 10.3%) and mixed dysphagia (5/78, 6.4%). The most common concomitant symptoms were chest pain (40/78, 51.3%), regurgitation (34/78, 43.6%), heartburn (20/78, 25.6%), weight loss (19/78, 24.3%) and cough (14/78, 17.9%). Median age was 57.0, with M/F ratio of 33/78 (42.3%). Endoscopy showed abnormal features in 25/78 (32.1%), with the most common finding being erosive esophagitis (5/25, 20%). Seven out of 25 (28%) subjects had at least one non-specific finding among those associated with eosinophilic esophagitis (edema, rings, exudate, furrowing, strictures). The physician performed biopsies of the esophagus and/or cardias in 52/78 (66.6%) cases, and 28 patients had histologic abnormal findings. The most common histological diagnosis was eosinophilic esophagitis (EoE) which was identified in 12 patients, 5/12 (41.7%) without mucosal evidence of EoE. HRM was performed in 22/30 patients (73.3%) after negative endoscopy and/or histology, with abnormal findings in 17/22 (77.3%) of the tests. In this setting achalasia was the most common diagnosis (5/22, 22.7%), one patient with Type I, two with Type II and two patients with Type III.
Overall, the most common diagnosis in our cohort was EoE (12/78, 15.4%), followed by achalasia (7/78, 9.0%).

Conclusion

Among patients complaining of dysphagia referred to an outpatient gastroenterology clinic, EoE is the main underlying cause of such condition. Given its high frequency, biopsies should be always performed in patients with dysphagia, regardless of endoscopic findings.

Conference

UEG Week Copenhagen 2023

Topics

Oesophagus

Submission format

Abstract

Session

PP 01 Oesophageal, gastric and duodenal disorders (Posters)

Citation

United European Gastroenterology Journal 2023; 11 (Supplement 8)

Published

2023

More Like This:

PREVENTION OF ACUTE PANCREATITIS RELATED ORGAN FAILURE WITH EARLY USE OF CELECOXIB -- AN INVESTIGATOR-INITIATED, PROSPECTIVE, MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL

Chengwei Tang

Summary: Acute pancreatitis: Are we still innocent bystanders?

Andrada Seicean

EFFECT OF SAME-SESSION ENDOSCOPIC ULTRASONOGRAPHY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PANCREATICOBILIARY DISEASES: A RANDOMIZED CONTROLLED TRIAL

Zefeng Xing

Understanding and targeting bile stone formation

Michael Trauner

ULTRASOUND ASSESSMENT OF QUADRICEPS MUSCLE THICKNESS AS A PROGNOSTIC TOOL IN ADVANCED CHRONIC LIVER DISEASE: A PROSPECTIVE STUDY

Bruno Manuel Santos Peixe

UEG Journal Best Paper Award

Mathias Cook

UEG Presentation

New

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

PREVENTION OF ACUTE PANCREATITIS RELATED ORGAN FAILURE WITH EARLY USE OF CELECOXIB -- AN INVESTIGATOR-INITIATED, PROSPECTIVE, MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

PREVENTION OF ACUTE PANCREATITIS RELATED ORGAN FAILURE WITH EARLY USE OF CELECOXIB -- AN INVESTIGATOR-INITIATED, PROSPECTIVE, MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL

Luming Huang 1, Libin Huang 1, Zhe Feng 1, Min Zhou 1, jingsun jiang 1, Xu Zeng 1, Zhiyin Huang 1, Chengwei Tang 1

Affiliations

1 West China Hospital, Sichuan University, Chengdu, China

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Introduction

Our previous multi-center randomized clinical trial (RCT) has confirmed that cyclooxygenase-2 (COX-2) inhibitors effectively shortened the duration of organ failure (OF) in patients with severe acute pancreatitis (SAP). We intended to clarify whether early use of COX-2 inhibitor celecoxib could prevent the occurrence of acute pancreatitis (AP) related OF, thereby further reducing the incidence of SAP.

Aims & Methods

A prospective, multi-center, double-blind, randomized, placebo-controlled clinical trial was conducted in 20 hospitals in China. Predicted non-mild AP patients with an interval from symptom onset to enrollment ≤48 hours, no OF (modified Marshall score ≤1 for any organ), a score of ‌systemic inflammatory response syndrome (SIRS) ≥2 or modified harmless acute pancreatitis score (HAPS) ≥2 were eligible for this study. They were randomly assigned into celecoxib group (200mg celecoxib oral twice a day for 7days) or the same dosage and course of placebo to placebo group. If the patients developed OF, the double-blind trial medication was discontinued and replaced with celecoxib (200mg oral twice a day) until the OF was fully alleviated. All of the enrolled patients accepted conventional treatments. The primary outcome was the occurrence of OF.

Results

From September 2025 to April 2026, 278 predicted non-mild AP patients were enrolled and randomly divided into the placebo group (n=142) and celecoxib group (n=136). The occurrence of OF in celecoxib group (16.9%) was significantly reduced compared with those in placebo group (35.9%), p<0.001. Accordingly, the incidence of SAP was also significantly lower in the celecoxib group (5.9% vs 18.3%, p=0.002). In addition, the duration of OF in the celecoxib group (preventive) was significantly shorter than that of the placebo group (therapeutic) with median 1.0 days [IQR 1.0-2.4] vs 1.8 days [1.0-3.0], p=0.038. Subgroup analysis based on the interval from symptom onset to enrolment (≤24 hours or >24 hours) showed that the success rate of OF prevention of the celecoxib group was higher in the former.

Conclusion

Early use of COX-2 inhibitor celecoxib effectively decreased the occurrence of AP related OF, thus reducing the incidence of SAP. The earlier COX-2 inhibitor was used after AP onset, the better the effect it would have.

Event

UEG Week Barcelona 2026

Topics

Pancreas Mechanisms & Personalised Medicine

Submission format

Abstract

Session

Acute pancreatitis: From prevention to treatment

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

PREVENTION OF ACUTE PANCREATITIS RELATED ORGAN FAILURE WITH EARLY USE OF CELECOXIB -- AN INVESTIGATOR-INITIATED, PROSPECTIVE, MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL

Chengwei Tang

Summary: Acute pancreatitis: Are we still innocent bystanders?

Andrada Seicean

EFFECT OF SAME-SESSION ENDOSCOPIC ULTRASONOGRAPHY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PANCREATICOBILIARY DISEASES: A RANDOMIZED CONTROLLED TRIAL

Zefeng Xing

Understanding and targeting bile stone formation

Michael Trauner

ULTRASOUND ASSESSMENT OF QUADRICEPS MUSCLE THICKNESS AS A PROGNOSTIC TOOL IN ADVANCED CHRONIC LIVER DISEASE: A PROSPECTIVE STUDY

Bruno Manuel Santos Peixe

UEG Journal Best Paper Award

Mathias Cook

UEG Presentation

New

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Summary: Acute pancreatitis: Are we still innocent bystanders?

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

Summary: Acute pancreatitis: Are we still innocent bystanders?

Andrada Seicean 1

Affiliations

1 University of Medicine and Pharmacy Iuliu Hatieganu Cluj-Napoca, Romania, Cluj Napoca, Romania

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Event

Postgraduate Teaching Programme Barcelona 2026

Topics

Surgery Pancreas Endoscopy

Session

Acute pancreatitis: Are we still innocent bystanders?

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

PREVENTION OF ACUTE PANCREATITIS RELATED ORGAN FAILURE WITH EARLY USE OF CELECOXIB -- AN INVESTIGATOR-INITIATED, PROSPECTIVE, MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL

Chengwei Tang

Summary: Acute pancreatitis: Are we still innocent bystanders?

Andrada Seicean

EFFECT OF SAME-SESSION ENDOSCOPIC ULTRASONOGRAPHY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PANCREATICOBILIARY DISEASES: A RANDOMIZED CONTROLLED TRIAL

Zefeng Xing

Understanding and targeting bile stone formation

Michael Trauner

ULTRASOUND ASSESSMENT OF QUADRICEPS MUSCLE THICKNESS AS A PROGNOSTIC TOOL IN ADVANCED CHRONIC LIVER DISEASE: A PROSPECTIVE STUDY

Bruno Manuel Santos Peixe

UEG Journal Best Paper Award

Mathias Cook

UEG Presentation

New

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

EFFECT OF SAME-SESSION ENDOSCOPIC ULTRASONOGRAPHY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PANCREATICOBILIARY DISEASES: A RANDOMIZED CONTROLLED TRIAL

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

EFFECT OF SAME-SESSION ENDOSCOPIC ULTRASONOGRAPHY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PANCREATICOBILIARY DISEASES: A RANDOMIZED CONTROLLED TRIAL

Zhen Li 1, Yile Zeng 1, Zefeng Xing 1

Affiliations

1 Qilu Hospital of Shandong University, Jinan, China

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Introduction

Endoscopic Ultrasonography (EUS) is increasingly being used in preoperative examinations in pancreatobiliary diseases for Endoscopic retrograde cholangiopancreatography (ERCP). However, it has never been tested in a randomized trial. This study aims to investigate the clinical value of performing EUS prior to ERCP versus performing conventional ERCP alone, focusing on avoiding unnecessary procedures, ensuring treatment concordance, reducing radiation exposure, and preventing complications.

Aims & Methods

In this single-center, parallel-group randomized controlled trial, patients with pancreaticobiliary diseases and a clear indication for ERCP were enrolled. Using a random number table, participants were assigned to either the EUS+ERCP group or the ERCP alone group. The primary outcomes were the rate of avoided unnecessary ERCP and the concordance rate between actual and initially planned interventional strategies. Secondary outcomes included technical success, difficult cannulation, procedure time, radiation dose, and complications.

Results

A total of 208 patients were randomized (105 to EUS+ERCP, 103 to ERCP alone). In the EUS+ERCP group, ERCP was avoided in 18 patients (17.1%) because EUS findings precluded the need for intervention. Among patients who proceeded to ERCP, the strategy concordance rate was significantly higher in the EUS+ERCP group (78/87, 89.7%) than in the ERCP alone group (74/103, 71.8%) (P = 0.002). The EUS+ERCP group also had significantly lower fluoroscopy time, radiation dose, DAP (Dose area product), and ERCP procedure time (P < 0.05). No significant differences were observed between groups in technical success, difficult cannulation, total procedure time, or complication rates (all P>0.05).

Conclusion

Performing EUS prior to ERCP significantly improves concordance between the interventional strategy and the procedure, safely reduces unnecessary ERCP procedures, and lowers radiation exposure. These findings suggest that pre-procedural EUS should be considered, when feasible, for patients with an indication for ERCP to optimize clinical decision-making.

Event

UEG Week Barcelona 2026

Topics

Radiology & Imaging Hepatobiliary Endoscopy

Submission format

Abstract

Session

Endoscopy: Taming the biliary tree

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

PREVENTION OF ACUTE PANCREATITIS RELATED ORGAN FAILURE WITH EARLY USE OF CELECOXIB -- AN INVESTIGATOR-INITIATED, PROSPECTIVE, MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL

Chengwei Tang

Summary: Acute pancreatitis: Are we still innocent bystanders?

Andrada Seicean

EFFECT OF SAME-SESSION ENDOSCOPIC ULTRASONOGRAPHY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PANCREATICOBILIARY DISEASES: A RANDOMIZED CONTROLLED TRIAL

Zefeng Xing

Understanding and targeting bile stone formation

Michael Trauner

ULTRASOUND ASSESSMENT OF QUADRICEPS MUSCLE THICKNESS AS A PROGNOSTIC TOOL IN ADVANCED CHRONIC LIVER DISEASE: A PROSPECTIVE STUDY

Bruno Manuel Santos Peixe

UEG Journal Best Paper Award

Mathias Cook

UEG Presentation

New

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Understanding and targeting bile stone formation

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

Understanding and targeting bile stone formation

Michael Trauner 1

Affiliations

1 Medical University of Vienna, Vienna, Austria

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Event

UEG Week Barcelona 2026

Topics

Paediatrics Radiology & Imaging Hepatobiliary Endoscopy

Session

Let’s talk about bile ducts: From stones to cholestasis

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

PREVENTION OF ACUTE PANCREATITIS RELATED ORGAN FAILURE WITH EARLY USE OF CELECOXIB -- AN INVESTIGATOR-INITIATED, PROSPECTIVE, MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL

Chengwei Tang

Summary: Acute pancreatitis: Are we still innocent bystanders?

Andrada Seicean

EFFECT OF SAME-SESSION ENDOSCOPIC ULTRASONOGRAPHY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PANCREATICOBILIARY DISEASES: A RANDOMIZED CONTROLLED TRIAL

Zefeng Xing

Understanding and targeting bile stone formation

Michael Trauner

ULTRASOUND ASSESSMENT OF QUADRICEPS MUSCLE THICKNESS AS A PROGNOSTIC TOOL IN ADVANCED CHRONIC LIVER DISEASE: A PROSPECTIVE STUDY

Bruno Manuel Santos Peixe

UEG Journal Best Paper Award

Mathias Cook

UEG Presentation

New

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

ULTRASOUND ASSESSMENT OF QUADRICEPS MUSCLE THICKNESS AS A PROGNOSTIC TOOL IN ADVANCED CHRONIC LIVER DISEASE: A PROSPECTIVE STUDY

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

ULTRASOUND ASSESSMENT OF QUADRICEPS MUSCLE THICKNESS AS A PROGNOSTIC TOOL IN ADVANCED CHRONIC LIVER DISEASE: A PROSPECTIVE STUDY

Margarida Portugal 1, Marta Eusébio 1, Isabel Malta Carvalho 1, Catarina Aguieiras 1, Marta Filipe da Silva Lobo Ferreira 1, Bruno Manuel Santos Peixe 1

Affiliations

1 ULS Algarve, Faro, Portugal

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Introduction

Advanced chronic liver disease (ACLD) is characterized by a hypercatabolic state leading to progressive muscle loss and sarcopenia, affecting up to 40% of patients. Sarcopenia is associated with increased mortality, higher risk of hepatic decompensation, and worse clinical outcomes. Although computed tomography is the gold standard for muscle mass assessment, its use is limited by cost, radiation exposure, and accessibility. Muscle ultrasound has emerged as a simple, non-invasive bedside alternative. Advanced chronic liver disease (ACLD) is characterized by a hypercatabolic state leading to progressive muscle loss and sarcopenia, affecting up to 40% of patients. Sarcopenia is associated with increased mortality, higher risk of hepatic decompensation, and worse clinical outcomes. Although computed tomography is the gold standard for muscle mass assessment, its use is limited by cost, radiation exposure, and accessibility. Muscle ultrasound has emerged as a simple, non-invasive bedside alternative.

Aims & Methods

This study aimed to evaluate the prognostic value of quadriceps muscle ultrasound in patients with ACLD, focusing on hepatic decompensation and 6-month mortality.
We conducted a prospective, single-center observational study including 55 consecutive hospitalized patients with ACLD in 2024. Muscle ultrasound was performed within 48 hours of admission using a 7.5–10 MHz linear probe, with patients in the supine position. Quadriceps thickness was measured at two-thirds of the distance between the anterior superior iliac spine and the patella. Three measurements per limb were obtained, and the mean value was normalized to height (thickness/height ratio). Primary outcomes were hepatic decompensation and 6-month mortality.

Results

Patients were predominantly male (85.5%), with a mean age of 60 years; alcohol-related liver disease was the leading etiology (69%). Median MELD-Na was 20, and most patients were Child-Pugh C. The mean thickness/height ratio was 7.22 ± 2.11 cm/m. During follow-up, 34.5% developed hepatic decompensation and 38.2% died.
ROC analysis demonstrated good discrimination for hepatic decompensation (AUC = 0.698; p = 0.02) and moderate discrimination for mortality (AUC = 0.638; p = 0.04). Optimal cut-offs were 7.95 cm/m and 7.0 cm/m, respectively. Patients with lower thickness/height ratio had a markedly increased risk of hepatic decompensation (OR ≈ 9; p = 0.01) and mortality (OR ≈ 5; p = 0.03). Kaplan–Meier analysis revealed significantly earlier decompensation and reduced survival in patients with lower muscle thickness (log-rank p < 0.05 for both outcomes).

Conclusion

Quadriceps muscle ultrasound is a simple, rapid, and reproducible bedside tool for assessing muscle mass in ACLD. The thickness/height ratio demonstrated significant prognostic value, with lower values associated with increased risk and earlier occurrence of hepatic decompensation and mortality. These findings support the integration of muscle ultrasound into routine clinical assessment of ACLD patients. Limitations include small sample size, single-center design, and lack of functional muscle assessment.

References

Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol. 2016 Dec;65(6):1232-1244.;
Ooi PH, Hager A, et al. Sarcopenia in Chronic Liver Disease: Impact on Outcomes. Liver Transpl. 2019 Sep;25(9):1422-1438.;
Tandon P, Low G, et al. A Model to Identify Sarcopenia in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2016 Oct;14(10):1473-1480.e3.;
Mahmoud H, Kamal H, El-Liethy N, et al. Value of ultrasound in grading the severity of sarcopenia in patients with hepatic cirrhosis. Egypt J Radiol Nucl Med. 2021;52:295.;
Flagiello V, et al. Ultrasound-Defined Sarcopenia Independently Predicts Acute Decompensation in Advanced Chronic Liver Disease. Dig Liver Dis. 2021;56(Suppl 1):S71-S72.;
Gödiker J, Schwind L, Jacob T, Böhling N, Reinartz Groba SN, Kimmann M, et al. Assessment of sarcopenia and outcome with ultrasound-based measurements in patients with liver cirrhosis. Liver Int. 2021.

Event

UEG Week Barcelona 2026

Topics

Mechanisms & Personalised Medicine Radiology & Imaging Hepatobiliary

Submission format

Abstract

Session

Liver cirrhosis: A cirrhotic conundrum - Diagnosis and evaluation

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

PREVENTION OF ACUTE PANCREATITIS RELATED ORGAN FAILURE WITH EARLY USE OF CELECOXIB -- AN INVESTIGATOR-INITIATED, PROSPECTIVE, MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL

Chengwei Tang

Summary: Acute pancreatitis: Are we still innocent bystanders?

Andrada Seicean

EFFECT OF SAME-SESSION ENDOSCOPIC ULTRASONOGRAPHY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PANCREATICOBILIARY DISEASES: A RANDOMIZED CONTROLLED TRIAL

Zefeng Xing

Understanding and targeting bile stone formation

Michael Trauner

ULTRASOUND ASSESSMENT OF QUADRICEPS MUSCLE THICKNESS AS A PROGNOSTIC TOOL IN ADVANCED CHRONIC LIVER DISEASE: A PROSPECTIVE STUDY

Bruno Manuel Santos Peixe

UEG Journal Best Paper Award

Mathias Cook

UEG Presentation

New

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Not sure what you can access? Learn more about account types.

UEG Journal Best Paper Award

Mathias Cook 1

Affiliations

1 Aalborg University Hospital, Aalborg, Denmark

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

Abstract

Event

UEG Week Barcelona 2026

Topics

Endoscopy IBD

Session

Hot topics in European Gastroenterology

Citation

2026: United European Gastroenterology Journal 2026; 14 (S1)

Published

2026

More Like This:

PREVENTION OF ACUTE PANCREATITIS RELATED ORGAN FAILURE WITH EARLY USE OF CELECOXIB -- AN INVESTIGATOR-INITIATED, PROSPECTIVE, MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL

Chengwei Tang

Summary: Acute pancreatitis: Are we still innocent bystanders?

Andrada Seicean

EFFECT OF SAME-SESSION ENDOSCOPIC ULTRASONOGRAPHY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PANCREATICOBILIARY DISEASES: A RANDOMIZED CONTROLLED TRIAL

Zefeng Xing

Understanding and targeting bile stone formation

Michael Trauner

ULTRASOUND ASSESSMENT OF QUADRICEPS MUSCLE THICKNESS AS A PROGNOSTIC TOOL IN ADVANCED CHRONIC LIVER DISEASE: A PROSPECTIVE STUDY

Bruno Manuel Santos Peixe

UEG Journal Best Paper Award

Mathias Cook